Last reviewed · How we verify

NCT07531823

Evaluation of Indian Gooseberry/ Amla in the Management of Chronic Periodontitis

Completed NA Last updated 15 April 2026
What this trial tests

NA trial testing Scaling and root planing + Amla in Chronic Periodontitis in 30 participants. Completed in 15 September 2022.

Timeline
20 January 2020
Primary endpoint
15 March 2022
15 September 2022

Quick facts

Lead sponsorMahatma Gandhi Postgraduate Institute of Dental Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date20 January 2020
Primary completion15 March 2022
Estimated completion15 September 2022
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Mahatma Gandhi Postgraduate Institute of Dental Sciences

Who can join

Adults 18 to 60, any sex, with Chronic Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the influence of amla (Emblica officinalis) on patients with chronic generalized periodontitis, using a single-blind, randomized controlled study design. 1. At baseline, all participants fulfilling the I/E criteria would be randomized into Arm I or II. 2. All participants in Arm I and II would undergo scaling and root planing (SRP). 3. After 1 month, Arm I participants would receive adjunct amla for 2 weeks, and Arm II participants would receive no treatment. 4. Both arms would be followed until the end of 6 months and evaluated for clinical and biochemical parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Periodontitis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07531823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing